News | Press Releases

---

July 26, 2006

TOSHIBA’S NEW NEMIO XG ULTRASOUND UPGRADE IMPROVES DIAGNOSIS AND PATIENT CARE

Newly Available Clinical Applications Enhance Image Quality, Accuracy and Efficiency

TUSTIN, Calif., July 26, 2006 – Toshiba America Medical Systems, Inc. today announced the availability of a new upgrade for the popular NemioT ultrasound system. Using next-generation technology, the Nemio XG provides the image quality needed to render a fast, accurate diagnosis – limiting the number of patients who are referred for more serious procedures, testing and follow up.

“We are constantly advancing our ultrasound technologies and the next generation Nemio XG provides cutting-edge benefits for both doctors and patients,” said Gordon Parhar, director, Ultrasound Business Unit, Toshiba. “This technology, with its increased clinical applications and improved image quality, will allow many patients to receive a diagnosis in just one doctor visit, rather than receiving an ultrasound and then possibly a second test, like an MRI. The level of diagnostic confidence is increased significantly by the Nemio XG.”

The next-generation Nemio XG features enhancements from Toshiba’s flagship Xario ultrasound system, designed to expand diagnostic capabilities and improve clinical insight. Using highly developed clinical applications, the Nemio XG technology provides:

• ADF (Advanced Dynamic Flow) — a more sensitive color Doppler and more detailed images for faster, more accurate diagnosis
• QuickScan — optimized 2D images with the touch of a button
• ApliPure — faster image acquisition and greater clarity

These advancements increase system utility and provide sharp, crisp images that improve visualization of the smallest details. And, with complete network connectivity, doctors can speed information delivery and expedite a higher quality of patient care.

“Ultimately, we want to make everything easier for our customers’ patients,” Parhar says. “The Nemio XG will offer more information in less time, which is a sizable patient benefit.”

For more information about the Nemio XG, Toshiba and its wide range of medical imaging products, please visit www.medical.toshiba.com.

About Toshiba
With headquarters in Tustin, Calif., Toshiba America Medical Systems markets, sells, distributes and services diagnostic imaging systems, and coordinates clinical diagnostic imaging research for all modalities in the United States. Toshiba Medical Systems Corp., an independent group company of Toshiba Corp., is a global leading provider of diagnostic medical imaging systems and comprehensive medical solutions, such as CT, Cath & EP Labs, X-ray, Ultrasound, Nuclear Medicine, MRI and information systems. Toshiba Corp. is a leader in information and communications systems, electronic components, consumer products, and power systems. Toshiba has approximately 161,000 employees worldwide and annual sales of $54 billion.